$64.54
-1.88 (-2.83%)
Performance
1D
—
1W
—
1M
—
3M
-17.85%
6M
+9.41%
1Y
+14.70%
YTD
-15.90%
Open$64.78
Previous Close$66.42
Day High$65.29
Day Low$64.00
52W High$87.50
52W Low$35.95
Volume—
Avg Volume1.02M
Market Cap5.58B
P/E Ratio7.43
EPS$8.53
SectorBiotechnology
Technical Indicators
Full analysis →
SMA 50
$75.08
Below
SMA 200
$61.55
Above
RSI (14)
25.1
Oversold
Trend
Golden Cross
Bullish
Analyst Ratings
Buy
22 analysts
Price Target
+20.8% upside
Current
$64.54
$64.54
Target
$77.98
$77.98
$54.55
$77.98 avg
$125.35
Key Financials
| FY 2026 | FY 2025 | FY 2024 | |
|---|---|---|---|
| Revenue | 875.68M | 765.32M | 623.61M |
| Net Income | -394,318,222 | -310,161,160 | 103.27M |
| Profit Margin | -45.0% | -42.8% | 16.6% |
| EBITDA | -145,212,798 | -120,566,472 | 195.81M |
| Free Cash Flow | — | — | 61.49M |
| Rev Growth | +14.4% | +14.4% | +11.8% |
| Debt/Equity | 848.93 | 848.93 | 0.18 |
Biotechnology Peers
| Symbol | Name | Price | Change | P/E | Mkt Cap |
|---|---|---|---|---|---|
| ABBV | Abbvie Inc | $205.20 | +0.13% | 166.6 | 397.77B |
| AMGN | Amgen Inc | $348.43 | -0.38% | 24.4 | 188.06B |
| GILD | Gilead Sciences Inc | $138.11 | +0.56% | 20.0 | 170.34B |
| VRTX | Vertex Pharmaceuticals Inc | $448.62 | -0.58% | 29.2 | 115.53B |
| REGN | Regeneron Pharmaceuticals | $741.69 | +0.70% | 17.9 | 80.50B |
| ALNY | Alnylam Pharmaceuticals Inc | $308.05 | +0.45% | 139.7 | 43.84B |